Come up with a name for your new list and we'll add to it:
Cardiorentis raised a round of funding on September 17, 2014. Investors include
HealthCare Royalty Partners.
Cardiorentis is a biopharmaceutical company that is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases. The company's disease-based technology …